Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
PR Newswire•04/08/2026•15:29 ET
0
Whiz Insights
Get started
Create a free account to read the full story.